Risk Factors for Pediatric Difficult Supraglottic Airway Placement and Ventilation (PEDSGAP)

February 14, 2026 updated by: Alper Kilicaslan

Risk Factors for Pediatric Difficult Supraglottic Airway Placement and Ventilation (PEDSGAP): A Multicentric Prospective Observational Study

This study is designed to observe the occurrence of failure or difficulty during placement of supraglottic airway devices (SGAs) and its associated risk factors in pediatric patients. Despite wide use in pediatric practice, not much is known related to problems during SGA insertion unlike adults. The main information regarding pediatric SGA comes from either small comparative studies or retrospective studies reporting increased risk of failure. Thus the main aim of this prospective, multicentric, observational study is to determine the incidence of "difficult" or "failed" SGA placement in children and clarify the possible risk factors for difficulty.

Study Overview

Status

Completed

Detailed Description

Inclusion criteria

  • 1- 12 years old peditatric patients
  • ASA class I- III
  • Scheduled for elective surgery under general anaesthesia, in whom a SGA would be used for airway maintenance
  • Planned surgery under general anesthesia with SGA
  • Patients whose legal guardians provide informed consent

Exclusion criteria

  • Refusal to participate in the study.
  • Inability of patient or parents to understand the study or consent process
  • Orotracheal intubation requirement
  • Pathology of airway, neck, respiratory tract, upper gastrointestinal tract
  • Increased risk of regurgitation or aspiration
  • Emergency surgeries
  • Requirement for intensive care follow-up after the surgery

Study Type

Observational

Enrollment (Actual)

3750

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey (Türkiye)
        • Asli Dönmez
      • Istanbul, Turkey (Türkiye)
        • Emre Sertaç Bingül
      • Izmir, Turkey (Türkiye)
        • Gaye Aydin
      • Kayseri, Turkey (Türkiye)
        • Sibel Seckin Pehlivan
      • Konya, Turkey (Türkiye)
        • Necmettin Erbakan University
      • Trabzon, Turkey (Türkiye)
        • Sedat Saylan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

1- 12 years old peditatric patients scheduled for elective surgery under general anaesthesia, in whom a SGA would be used for airway maintenance

Description

Inclusion Criteria:

  • 1- 12 years old peditatric patients
  • ASA class I- III
  • Planned surgery under general anesthesia with supraglottic airway
  • Patients whose legal guardians provide informed consent

Exclusion Criteria:

  • Refusal to participate in the study
  • Inability of patient or parents to understand the study or consent process
  • Orotracheal intubation requirement
  • Pathology of airway, neck, respiratory tract, upper gastrointestinal tract
  • Increased risk of regurgitation or aspiration

    • Emergency surgeries
    • Requirement for intensive care follow-up after the surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of difficulty in supraglottic airway device(SGA) placement
Time Frame: Immediately after the attempt of insertion and up to the end of the surgery
Difficulty in placing SGA is defined as follows: SGA insertion that requires more than one attempt,need for a change the size or type of SGA,desatutaion (SpO2<93%), disrupted capnography,high airway pressure (>25 cmH2O of peak pressure)
Immediately after the attempt of insertion and up to the end of the surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors for pediatric difficult SGA placement
Time Frame: At the beginning of anesthesia
Possible risk factors related with failure and difficulty listed as:experience of the anaesthetist , presence of history of asthma/pneumoniae,presence of craniofascial anomalies, use of neuromuscular blocking agent, type and placement technique of SGA
At the beginning of anesthesia
The incidence of complications related to SGA insertion
Time Frame: Up to 24 hours after surgery
The incidence of adverse events including laryngospasm, desaturation bronchospasm, stridor, regurgitation bucking, airway trauma and postoperative complications including difficult weaning, cough, stridor, vomiting, dysfagia, dysphonia
Up to 24 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alper Kilicaslan, Necmettin Erbakan Universty Medical Faculty

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2023

Primary Completion (Actual)

March 30, 2024

Study Completion (Actual)

April 1, 2024

Study Registration Dates

First Submitted

September 26, 2023

First Submitted That Met QC Criteria

October 5, 2023

First Posted (Actual)

October 10, 2023

Study Record Updates

Last Update Posted (Actual)

February 17, 2026

Last Update Submitted That Met QC Criteria

February 14, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2023/4546

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

Subscribe